Amgen Inc at Bank of America Merrill Lynch Global Healthcare Conference Transcript

Sep 14, 2023 / 10:40AM GMT
Daniel Lundquist -

Hello. Good afternoon, everybody. I'm Dan Lundquist, healthcare -- U.S. health care specialists at Bank of America, and thank you for joining day 2 in London. Very pleased today to be hosting Amgen. From Amgen, we have Peter Griffith, the CFO; as well as Arvind and Justin from the Investor Relations team. I have a number of questions, but do feel free out in the audience if you have questions to raise your hand. We'll bring the microphone over to you and we can have your question answered.

With that, let me just open it up to you, Peter, just in terms of kind of your thoughts around 2Q. Any comments you want to make, and then we'll launch right into Q&A.

Peter H. Griffith - Amgen Inc. - Executive EVP & CFO

Fantastic. Thank you, Dan, and welcome, everybody. It's great to see you. We're so glad to be here, make the trip over. And as we always do at Amgen, we start with patients and our mission to serve patients through discovering, developing, manufacturing and delivering first-in-class and best-in-class medicines to patients with

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
4.6 out of 5 Trustpilot